Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
GENERAL ELECTRIC CO | Director | Deferred Fee Phantom Stock Units | 13.3K | $1.64M | $123.54 | Jan 3, 2023 | Direct |
Merck & Co., Inc. | Director | Phantom Stock | 12.1K | $1.52M | $125.54 | May 31, 2024 | Direct |
INTEL CORP | Director | Common Stock | 29.8K | $902K | $30.29 | May 7, 2024 | Direct |
GE HealthCare Technologies Inc. | Director | Common Stock, par value $0.01 per share | 7.07K | $576K | $81.54 | May 21, 2024 | Direct |
INTEL CORP | Director | Restricted Stock Units | 7.4K | $230K | $31.03 | May 8, 2024 | Direct |
Merck & Co., Inc. | Director | Common Stock | 1K | $128K | $127.51 | May 31, 2024 | Direct |
Better Therapeutics, Inc. | Director | Common Stock | 13.8K | $2.34K | $0.17 | Dec 18, 2023 | Direct |
Better Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 15K | Jun 7, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
MRK | Merck & Co., Inc. | May 31, 2024 | 1 | $220K | 4 | Jun 4, 2024 | Director |
GEHC | GE HealthCare Technologies Inc. | May 21, 2024 | 1 | $0 | 4 | May 23, 2024 | Director |
INTC | INTEL CORP | May 8, 2024 | 1 | $0 | 4 | May 10, 2024 | Director |
INTC | INTEL CORP | May 7, 2024 | 2 | $0 | 4 | May 9, 2024 | Director |
BTTX | Better Therapeutics, Inc. | Dec 18, 2023 | 1 | $0 | 4 | Dec 20, 2023 | Director |
BTTX | Better Therapeutics, Inc. | Jun 7, 2023 | 1 | $0 | 4 | Jun 9, 2023 | Director |
MRK | Merck & Co., Inc. | May 26, 2023 | 1 | $220K | 4 | May 31, 2023 | Director |
GEHC | GE HealthCare Technologies Inc. | May 23, 2023 | 1 | $0 | 4 | May 25, 2023 | Director |
INTC | INTEL CORP | May 11, 2023 | 3 | $0 | 4 | May 15, 2023 | Director |
GEHC | GE HealthCare Technologies Inc. | Jan 3, 2023 | 2 | $0 | 4 | Jan 5, 2023 | Director |
GEHC | GE HealthCare Technologies Inc. | Jan 3, 2023 | 0 | $0 | 3 | Jan 5, 2023 | Director |
GE | GENERAL ELECTRIC CO | Jan 3, 2023 | 1 | $42.8K | 4 | Jan 5, 2023 | Director |
GE | GENERAL ELECTRIC CO | Oct 1, 2022 | 1 | $42.8K | 4 | Oct 4, 2022 | Director |
GE | GENERAL ELECTRIC CO | Jul 1, 2022 | 1 | $42.8K | 4 | Jul 6, 2022 | Director |
BTTX | Better Therapeutics, Inc. | Jun 9, 2022 | 1 | $0 | 4 | Jun 10, 2022 | Director |
MRK | Merck & Co., Inc. | May 27, 2022 | 1 | $220K | 4 | Jun 1, 2022 | Director |
INTC | INTEL CORP | May 12, 2022 | 3 | $0 | 4 | May 16, 2022 | Director |
GE | GENERAL ELECTRIC CO | Apr 1, 2022 | 1 | $42.8K | 4 | Apr 4, 2022 | Director |
INTC | INTEL CORP | Jan 30, 2022 | 2 | $0 | 4 | Feb 1, 2022 | Director |
GE | GENERAL ELECTRIC CO | Jan 3, 2022 | 1 | $42.8K | 4 | Jan 4, 2022 | Director |
BTTX | Better Therapeutics, Inc. | Dec 21, 2021 | 1 | $46K | 4 | Dec 23, 2021 | Director |
BTTX | Better Therapeutics, Inc. | Oct 28, 2021 | 1 | $0 | 4 | Nov 1, 2021 | Director |
BTTX | Better Therapeutics, Inc. | Oct 28, 2021 | 0 | $0 | 3 | Nov 1, 2021 | Director |
INTC | INTEL CORP | Oct 25, 2021 | 1 | $248K | 4 | Oct 26, 2021 | Director |
GE | GENERAL ELECTRIC CO | Oct 1, 2021 | 1 | $42.7K | 4 | Oct 1, 2021 | Director |
GE | GENERAL ELECTRIC CO | Jul 1, 2021 | 1 | $42.7K | 4 | Jul 1, 2021 | Director |
MRK | Merck & Co., Inc. | May 28, 2021 | 1 | $200K | 4 | Jun 2, 2021 | Director |
INTC | INTEL CORP | May 13, 2021 | 3 | $0 | 4 | May 17, 2021 | Director |